The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Viatris Inc. (NASDAQ: VTRS) who purchased common stock between March 1, 2021 and February 25, 2022. The action, which was filed in the United States District Court for the Western District of Pennsylvania, alleges that the Company violated federal securities laws.
In particular, the Viatris lawsuit alleges that i) the Company was experiencing significantly more competition in its United States complex generics business than disclosed; (ii) the Company was not able to effectively manage its base business erosion or create a stable revenue base; (iii) despite being on the Company’s only growth drivers, Viatris was actively planning to divest its biosimilars business in order to secure enough cash to let it purportedly meet its phase one goals; (iv) Viatris was deviating from the business model it touted throughout the Class Period and undertaking a significant global reshaping of its business which would undermine its ability to achieve stable revenue growth; and (v) the Company was anticipating less financial growth moving into 2022.
Shareholders have until July 14, 2023 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
To learn more and keep informed, complete this form >